論文

査読有り
2018年6月

Efficacy, safety, and tolerability of lubiprostone for the treatment of non-alcoholic fatty liver disease in adult patients with constipation: The LUBIPRONE, double-blind, randomised, placebo-controlled study design.

Contemporary clinical trials
  • Kessoku T
  • ,
  • Imajo K
  • ,
  • Kobayashi T
  • ,
  • Honda Y
  • ,
  • Kato T
  • ,
  • Ogawa Y
  • ,
  • Tomeno W
  • ,
  • Kato S
  • ,
  • Higurashi T
  • ,
  • Yoneda M
  • ,
  • Kirikoshi H
  • ,
  • Kubota K
  • ,
  • Taguri M
  • ,
  • Yamanaka T
  • ,
  • Usuda H
  • ,
  • Wada K
  • ,
  • Saito S
  • ,
  • Nakajima A

69
開始ページ
40
終了ページ
47
DOI
10.1016/j.cct.2018.04.002

Web of Science ® 被引用回数 : 2

リンク情報
DOI
https://doi.org/10.1016/j.cct.2018.04.002
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/29627620
Web of Science
https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000435054600005&DestApp=WOS_CPL